S
Seiji Isonishi
Researcher at Jikei University School of Medicine
Publications - 84
Citations - 2636
Seiji Isonishi is an academic researcher from Jikei University School of Medicine. The author has contributed to research in topics: Ovarian cancer & Carboplatin. The author has an hindex of 21, co-authored 83 publications receiving 2412 citations.
Papers
More filters
Journal ArticleDOI
Effect of estrogen and progesterone on the growth of human ovarian dysgerminoma heterotransplanted to athymic nude mice.
TL;DR: The dysgerminoma used in this study was sex steroid hormone dependent and P alone or in combination with E could be a choice for the treatment of such ovarian dysgermineoma.
Journal ArticleDOI
Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary
Akihiro Ohyama,Junko Toyomura,Toshiaki Tachibana,Seiji Isonishi,Haruka Takahashi,Hiroshi Ishikawa +5 more
TL;DR: A cell line, established from the ascites of a patient with clear cell adenocarcinoma of the ovary, which is spherical to polygonal-shaped, display neoplastic, and pleomorphic features, and grow in a jigsaw puzzle-like pattern while forming monolayers without contact inhibition.
Journal ArticleDOI
Two cases of epidural anesthesia-associated postoperative decubitus
Eri Takahashi,Seiji Isonishi,Michiko Suzuki,Asako Ogura,Shiro Kunito,Masanori Hirama,Hirokazu Shoji,Kazuhiko Ochiai,Tadao Tanaka +8 more
TL;DR: It is concluded that the extended effect of epidural anesthesia might be one of the mechanisms causing postoperative decubitus.
Journal ArticleDOI
Use of Docetaxel After Paclitaxel Hypersensitivity Reaction in Epithelial Ovarian and Endometrial Cancer
TL;DR: The use of docetaxel is a reasonable approach for continuing taxane-based chemotherapy in patients with a paclitaxel hypersensitivity reaction, and early rechallenging with docetAXel is suggested for subsequent successful infusion.
Journal ArticleDOI
Mechanism-related circumvention of cisplatin resistance in human ovarian-carcinoma cells by (-)-(r)-2-aminomethylpyrrolidine(1,1-cyclobutanediacarboxylato)-platinum (ii) monohydrate and modulation of its sensitivity by 12-o-tetradecanoylphorbol-13-acetate
TL;DR: DWA2114R collateral sensitivity was due to its circumvention of impaired platinum accumulation in 2008/C13*5.25 cells to produce some collateral sensitivity, and TPA sensitization effect was not common to any platinum compounds but was strongly related to their ligands.